Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genital Neoplasms, Female”

8,291 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 8,291 results

Early research (Phase 1)Ended earlyNCT02317302
What this trial is testing

FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer

Who this might be right for
Cervical CancerUterine Cervical CancerUterine Cervical Neoplasms
Washington University School of Medicine 48
Not applicableUnknownNCT04172272
What this trial is testing

The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures

Who this might be right for
LeiomyomaPelvic Organ ProlapseAbnormal Uterine Bleeding+3 more
General Hospital Pula 75
Testing effectiveness (Phase 2)Study completedNCT03776812
What this trial is testing

Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Recurrent Ovarian CancerRecurrent Fallopian Tube CarcinomaRecurrent Primary Peritoneal Carcinoma
Corcept Therapeutics 178
Testing effectiveness (Phase 2)Study completedNCT00025467
What this trial is testing

Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial AdenoacanthomaEndometrial AdenocarcinomaEndometrial Adenosquamous Cell Carcinoma+3 more
National Cancer Institute (NCI) 60
Large-scale testing (Phase 3)Looking for participantsNCT06989112
What this trial is testing

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Who this might be right for
Endometrial Cancer
AstraZeneca 600
Not applicableStudy completedNCT05458869
What this trial is testing

Evaluating the Human Papillomavirus Self-Collection Experience in Individuals Who Have Experienced Sexual Trauma

Who this might be right for
Cervical CarcinomaHuman Papillomavirus Infection
OHSU Knight Cancer Institute 16
Not applicableActive Not RecruitingNCT06197802
What this trial is testing

Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 392
Not applicableLooking for participantsNCT05984875
What this trial is testing

The Immune Landscape of Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
Oncology Institute of Southern Switzerland 74
Early research (Phase 1)Study completedNCT03000257
What this trial is testing

Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
AbbVie 182
Not applicableUnknownNCT06273501
What this trial is testing

MRI and Magnetometer-guided Sentinel Lymph Node Detection in Vulvar Cancer

Who this might be right for
Vulvar CancerLymph Node Metastasis
Sahlgrenska University Hospital 20
Large-scale testing (Phase 3)Study completedNCT01131312
What this trial is testing

Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS)

Who this might be right for
Cervical Intraepithelial Neoplasia
National Cancer Institute (NCI) 5,060
Testing effectiveness (Phase 2)Study completedNCT00333502
What this trial is testing

Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors

Who this might be right for
CancerSolid Tumor
NewLink Genetics Corporation 62
Large-scale testing (Phase 3)Study completedNCT00850772
What this trial is testing

Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerPeritoneal CancerFallopian Tube Cancer
Queensland Centre for Gynaecological Cancer 109
Testing effectiveness (Phase 2)Ended earlyNCT02834975
What this trial is testing

Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC).

Who this might be right for
Fallopian Tube CancerPeritoneum CancerEpithelial Ovarian Cancer
University of Miami 26
Testing effectiveness (Phase 2)Ended earlyNCT00830401
What this trial is testing

The Impact of Treating Minor Uterine Cavity Abnormalities Diagnosed by Office Hysteroscopy in Unselected In Vitro Fertilization (IVF) Cases

Who this might be right for
Minor Intra-uterine Abnormalities
UMC Utrecht 700
Not applicableStudy completedNCT04240730
What this trial is testing

Transvaginal Natural Orifice Endoscopic Surgery for Extremely Obese Patients With Early-stage Endometrial Cancer

Who this might be right for
Endometrial CancerExtreme Obesity
Dr. Lutfi Kirdar Kartal Training and Research Hospital 6
Testing effectiveness (Phase 2)Study completedNCT00052065
What this trial is testing

TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
Telik 28
Not applicableStudy completedNCT04205864
What this trial is testing

Application of Thrombin Gel Matrix for the Prevention of Lymphocele in Patients With Endometrial Cancer.

Who this might be right for
LymphoceleLymphocele After Surgical ProcedureEndometrium Cancer
Kocaeli University 72
Testing effectiveness (Phase 2)Looking for participantsNCT05887609
What this trial is testing

An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib

Who this might be right for
Ovary CancerPeritoneal CancerFallopian Tube Cancer
University of Colorado, Denver 53
Not applicableStudy completedNCT03811899
What this trial is testing

18F-DCFPyL PET/CT in High-grade Epithelial Ovarian Cancer (PET HOC)

Who this might be right for
Stage III Ovarian CancerStage IV Ovarian Cancer
University Health Network, Toronto 20
Load More Results